Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 906.70
+11.50 (1.28%)
At close: Jul 27, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 15 billion as of July 27, 2026. Its market cap has increased by 244.47% in one year.
Market Cap
15.00B
Enterprise Value
16.77B
Revenue
6.35B
Ranking
n/a
PE Ratio
44.43
Stock Price
906.70
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 15.00B, an increase of 50,894.97%. That is a compound annual growth rate of 82.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 15.00B | 101.22% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 22.06B |
| TTK Healthcare | 14.82B |
| Amrutanjan Health Care | 14.76B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.40B |
| Syncom Formulations (India) | 12.31B |
| Lincoln Pharmaceuticals | 11.66B |
| Wanbury | 11.60B |